| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 95.39B | 100.20B | 95.49B | 90.57B | 83.84B | 81.49B |
| Gross Profit | 15.00B | 14.94B | 15.57B | 14.36B | 12.63B | 12.29B |
| EBITDA | 10.24B | 9.29B | 11.83B | 9.79B | 7.56B | 8.02B |
| Net Income | 2.44B | 4.03B | 3.79B | 3.85B | 1.59B | 2.79B |
Balance Sheet | ||||||
| Total Assets | 140.65B | 151.52B | 148.54B | 131.61B | 121.14B | 104.86B |
| Cash, Cash Equivalents and Short-Term Investments | 17.38B | 19.55B | 22.19B | 25.34B | 23.60B | 15.88B |
| Total Debt | 40.73B | 42.23B | 44.23B | 37.40B | 38.05B | 29.90B |
| Total Liabilities | 64.20B | 65.47B | 67.11B | 58.69B | 62.36B | 50.39B |
| Stockholders Equity | 74.22B | 83.49B | 79.11B | 70.81B | 56.85B | 52.72B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -819.00M | -9.21B | -6.53B | -520.00M | -3.77B |
| Operating Cash Flow | 0.00 | 7.82B | 9.06B | 9.44B | 6.25B | 2.48B |
| Investing Cash Flow | 0.00 | -6.88B | -18.75B | -14.21B | -6.60B | -6.11B |
| Financing Cash Flow | 0.00 | -4.10B | 4.70B | 5.38B | 6.91B | 1.57B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ¥46.87B | 9.49 | ― | 3.75% | 4.94% | 6.20% | |
67 Neutral | ¥6.40T | 64.56 | ― | 1.41% | 13.61% | 17.01% | |
67 Neutral | ¥45.40B | 12.31 | ― | 4.53% | 5.02% | 354.47% | |
67 Neutral | ¥1.14T | 31.17 | ― | 2.57% | 4.07% | 533.21% | |
62 Neutral | ¥227.41B | 12.56 | ― | 2.18% | -3.43% | 9.82% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | ¥89.69B | 13.36 | 2.26% | ― | 11.52% | 5786.05% |